课题基金 / 基金详情

Structures and Activities of Prions and Prion Proteins

Structures and Activities of Prions and Prion Proteins
朊病毒和朊病毒蛋白的结构和活性
批准号:
8555782
负责人:
BYRON CAUGHEY
金额:
$44.65万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

BYRON CAUGHEY的其他基金

相似基金

相关文献

中文摘要
翻译
2012财年的成就:我们已经在体外和体内确定了痒病菌株依赖的PrPSc与补体因子的相互作用。补体因子在中枢神经系统朊病毒感染中的作用尚不清楚。在这项研究中,我们评估了补体因子在神经2a (N2a)细胞和小鼠大脑的朊病毒感染中的株依赖性反应性。用正常小鼠血清(NMS)培养持续感染Chandler或22L痒病株的N2a细胞,用磷脂基丝氨酸结合蛋白和早期凋亡标志物Annexin V进行染色。在Chandler和22L感染的细胞中,Annexin V阳性细胞比例均增加。NMS与抗c1q、C3和/或C9抗体一起预孵生,可减少chandler感染细胞中的Annexin V阳性细胞,而只有抗C3抗体对22l感染细胞有效。免疫组化显示,C1q和C3在Chandler-和22l感染小鼠大脑中的沉积是不同的。这些结果表明,补体因子的反应性在体内和体外都存在差异。
英文摘要
Accomplishments for FY2012: We have identified scrapie strain-dependent interactions of PrPSc with complement factors in vitro and in vivo. Roles of complement factors in prion infection of the central nervous system remain unclear. In this study, we assessed the strain-dependent reactivity of complement factors in prion infections of Neuro2a (N2a) cells and mouse brains. N2a cells persistently infected with either Chandler or 22L scrapie strains were cultured in the presence of normal mouse serum (NMS), followed by staining with the phosphatidylserine binding protein and early apoptosis marker Annexin V. The proportion of Annexin V positive cells was increased both in Chandler- and 22L-infected cells. Preincubation of NMS with anti-C1q, C3 and/or C9 antibodies reduced Annexin V positive cells in Chandler-infected cells, while only anti-C3 antibodies were effective on 22L-infected cells. Immunohistochemistry showed that deposition of C1q and C3 was different between Chandler- and 22L-infected mouse brains. These results indicate that the reactivity of complement factors differs between prion strains both in vitro and in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prion Disease Therapeutics
Structures and Activities of Prions and Prion Proteins
Prion Disease Therapeutics
Detection of Prions
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: